Pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers may possibly decrease sufentanil degrees and efficacy, maybe precipitating withdrawal syndrome in sufferers who've developed Actual physical dependence to sufentanil. Discontinuation of concomitantly used CYP3A4 ... https://high-quality-nembutal79901.bloggerswise.com/27822713/pentobarbital-sodium-injection-an-overview